Sai Life Sciences Sustainability Report - 2023-24

30 CDMO companies serve as the backbone of pharmaceutical development and manufacturing, and the ability to innovate, directly impacts the speed, efficiency, and quality of bringing medicines to market. We are one of the largest integrated CRDMOs among listed Indian peers in terms of revenue from operations for the FY 2024, serving as a one-stop platform for discovery, development and manufacturing. We are present in the different phases of the value chain stages, which allows us to provide end-to-end support from discovery to commercialization. Enhancing sustained value co-creation with our customers and supply chain partners Value Chain Stages Phases Key Steps • Target lead identification • Lead Generation • Lead Optimization • Lead Selection • Biology Studies • Biological Analysis • Drug Metabolism, Pharmacokinetics (DMPK) • Toxicology studies (Safety studies) • Manufacturing Clinical Supplies • Phase 1,2,3 Clinical Trials • Drug Filing with Regulatory Authorities • Drug Substance Manufacturing (RSM, intermediates, APIs) & Formulation Research Development Pre-clinical development Clinical Development & Supplies Registration Commercial Manufacturing Contract Research, Development and Manufacturing Organizations (CRDMO) One stop service solution is a business model of pharmaceutical contract organization that provides services covering entire value chain Contract Research Organisation (CRO) Focus on the drug development, data management, and select analytical services Chemistry, Manufacturing and Control (CMC)/ Contract Development and Manufacturing Organization (CDMO) Focus on development and manufacturing Contract Manufacturing Organisation (CMO) Focus on development and manufacturing Drug Discovery Development & Clinical Supplies Commercial Manufacturing

RkJQdWJsaXNoZXIy MTIwMDc4NQ==